1800 202 8726
Surveillance scanning

Is Routine Surveillance PET — Actually Recommended?

For most cancers, guidelines do not recommend PET scans as part of routine follow-up. If your team has not ordered one, that is usually the right clinical decision — not an oversight.

Medically reviewed by Dr. T. Raghavender Reddy, Medical Oncologist, MBBS · DM (Medical Oncology) · MD (Radiation Oncology) · Last reviewed September 2026

  • Most cancers: no routine PET — NCCN, ASCO, and ESMO surveillance guidelines for the majority of solid tumours do not include scheduled PET scans.
  • A few cancers are different — Lymphomas and some head and neck cancers have a defined, timed role for PET — but not indefinite repeat scheduling.
  • More scans do not mean safer follow-up — Evidence shows routine PET after remission does not reliably detect recurrence earlier for most cancer types.
  • The harms are real and cumulative — Repeated PET scans add radiation dose, significant cost, and a high rate of false positives that trigger unnecessary procedures.
4.8 · 800+ Google reviews · 15,000+ patients treated
Limited Slots Today

Talk to a medical oncologist

₹950   Today: FREE  ·  Including free written second opinion

Reply within 2 working hours
Report reviewed by a senior oncologist
Confidential. No commitment to start treatment.
or
Call 1800 202 8726
17+
Cancer Specialists
on Panel
96.9%
Breast Cancer
Survival Rate*
15,000+
Patients
Treated
4.8★
Google Rating
(800+ reviews)

For the majority of cancers, routine surveillance PET is not supported by NCCN, ASCO, or ESMO guidance. It has a defined role for lymphomas and some head and neck cancers at specific, timed points. For most other cancers, guideline follow-up uses CT, blood markers, and clinical review — at lower dose and lower cost.

A whole-body PET-CT at CION costs from Rs 10,499 — among the lowest published prices in Hyderabad. Indicative price, as of September 2026.

Why do most cancer guidelines leave PET out of routine follow-up?

For most cancers, NCCN, ASCO, and ESMO do not include routine PET in their surveillance schedules. Evidence across most solid tumours shows that recurrence is caught just as effectively through scheduled CT, blood-based tumour markers, and symptoms you report yourself.

PET scans produce false-positive results when inflammation or normal tissue repair mimics tumour activity. Resolving a false positive can mean biopsy, additional scans, and months of distressing follow-up — none of which changes the outcome for the underlying cancer. Each scan also adds radiation dose and significant cost. The restraint in guidelines is evidence-based, not bureaucratic caution.

Which cancers include PET in surveillance — and which don't?

Cancer typeRoutine surveillance PET?What guidelines recommend
Hodgkin lymphomaEnd-of-treatment assessment only; not routine after remission is confirmedPET to confirm remission after treatment; CT and clinical review after that
Aggressive non-Hodgkin lymphoma (e.g. DLBCL)End-of-treatment assessment only; not ongoingEnd-of-treatment PET; CT and clinical review for ongoing follow-up
Head and neck cancersYes — one timed scan after completing chemoradiotherapy (NCCN)PET-CT at a defined point after treatment; clinical review thereafter
Breast cancerNo (ASCO Choosing Wisely)Mammography, clinical breast exam; imaging only if symptoms arise
Colorectal cancerNoCEA blood test, colonoscopy, CT of chest, abdomen and pelvis
Lung cancerNoCT chest at scheduled intervals; clinical review
Prostate cancerNoPSA blood test; imaging only if PSA rises or symptoms appear
Cervical cancerNoClinical and pelvic examination; imaging guided by symptoms

Not sure what this means for you?

Share your reports and a senior oncologist will explain your options in plain language — no obligation to start treatment.

PET-CT Partner Centres

PET-CT Scan Centres in Hyderabad

CION offers PET-CT scans through 4 trusted partner PET-CT centres across Hyderabad, so you can choose the one closest to you. Call 18002028726 and we’ll guide you to the earliest available appointment.

These are partner diagnostic centres within the CION network. Toll-free booking: 18002028726.

Meet the Specialists

17+ senior cancer specialists. One panel for your case.

Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.

Dr. Naresh Gundu
Medical Oncologist

Dr. Naresh Gundu

MBBS, DNB (Internal Medicine), DM (Medical Oncology)

View Profile
Dr. C. Raghavendra Reddy
Medical Oncologist

Dr. C. Raghavendra Reddy

MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)

View Profile
Dr. Bharati Devi Gorantla
Medical Oncologist

Dr. Bharati Devi Gorantla

MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)

View Profile
Dr. Owais Mohammed
Medical Oncologist

Dr. Owais Mohammed

MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)

View Profile
Dr. T. Raghavender Reddy
Medical Oncologist

Dr. T. Raghavender Reddy

MBBS, DM (Medical Oncology), MD (Radiation Oncology)

View Profile
Dr. N. Kiranmayee
Medical Oncologist

Dr. N. Kiranmayee

MBBS, DM (Medical Oncology), MD (Internal Medicine)

View Profile
Dr. Muralidhar Muddusetty
Surgical Oncologist

Dr. Muralidhar Muddusetty

MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)

View Profile
Dr. Raghavendra Naik
Surgical Oncologist

Dr. Raghavendra Naik

MBBS, MS (General Surgery), M.Ch (Surgical Oncology)

View Profile
Dr. Mohammed  Imaduddin
Surgical Oncologist

Dr. Mohammed Imaduddin

M.B.B.S, MS (General Surgery), M.Ch (Surgical Oncology)

View Profile
Dr. Vinay Mamidala
Surgical Oncologist

Dr. Vinay Mamidala

MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)

View Profile
Dr. Paila Gowri Naidu
Surgical Oncologist

Dr. Paila Gowri Naidu

MBBS, MS (General Surgery), M.Ch (Surgical Oncology), FMAS

View Profile
Dr. Venkata Sushma P
Radiation Oncologist

Dr. Venkata Sushma P

MBBS, MD (Radiation Oncology)

View Profile
Dr. Kirti Ranjan Mohanty
Radiation Oncologist

Dr. Kirti Ranjan Mohanty

MBBS, MD (Radiation Oncology)

View Profile
Dr. Gangadhar Vajrala
Radiation Oncologist

Dr. Gangadhar Vajrala

MBBS, MD (Radiation Oncology), MPH

View Profile
Dr. Basudev Pokhrel
Hematologist

Dr. Basudev Pokhrel

MBBS, M.D (Immunohematology & Blood Transfusion)

View Profile
Dr. Mohammed Imran
Interventional Radiologist

Dr. Mohammed Imran

View Profile
Dr. Vajja Sandeep Kumar
Surgical Oncologist

Dr. Vajja Sandeep Kumar

MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology

View Profile
Dr. Sridhar Kamani
Surgical Oncologist

Dr. Sridhar Kamani

MBBS, MS (General Surgery), DrNB (Surgical Oncology)

View Profile

Want a specific doctor for your case? Mention them when booking.

Book Free Consultation

You do not have to work this out alone

A 45-minute consultation with a specialist who treats this every week.

Book Free Consultation Call 1800 202 8726

What does over-scanning actually cost you?

  • Cumulative radiation doseEach PET-CT adds ionising radiation. The dose from a single scan is low, but it accumulates across years of surveillance.
  • False-positive resultsInflammation and healing look like cancer on PET. A false positive can mean biopsy and months of follow-up that resolve without any recurrence.
  • Incidental findings requiring workupScans frequently reveal unrelated findings — nodules, cysts, enlarged nodes — almost always benign but requiring their own investigation.
  • Significant cost, often uninsuredPET-CT in India carries a substantial indicative cost. Without a guideline indication, it may not be covered and falls entirely to you.
  • Scan anxiety on a repeating cycleKnowing a scan is approaching triggers distress. Scheduling scans without clinical indication extends that cycle without improving outcomes.

Questions families ask about surveillance planning

What if I feel anxious and want a scan my team has not ordered?

That anxiety is real and worth naming to your oncologist. Ask them to walk you through what the plan is monitoring, what symptoms should prompt an earlier call, and why the schedule is set as it is. That conversation often addresses the fear more effectively than a scan would — and it can surface a clinical reason to bring one forward if one genuinely exists.

How will recurrence be detected without a PET?

For most cancers, recurrence is caught through blood-based tumour markers checked regularly, CT on a scheduled basis, and symptoms you report between appointments. Your reports are part of the surveillance plan, not a gap in it. Unexplained weight loss, fatigue that does not improve, pain at the original site, or any new lump all need a same-day call rather than waiting for the next scheduled visit.

My previous oncologist ordered regular PETs — should I continue?

Surveillance practice has changed as evidence has accumulated, and some older plans included routine PETs that current guidelines no longer support. If your plan is being reviewed, ask whether regular PET is included in current NCCN or ESMO guidance for your cancer type at this stage. If it is not, a guideline-concordant plan reduces your dose, cost, and exposure to false-positive results.

I had lymphoma — do I need PET scans indefinitely?

Not indefinitely. PET plays its clearest role at the end of lymphoma treatment to confirm complete remission. After that, most ESMO and NCCN guidance moves to CT and clinical review, with PET reserved for situations where there is clinical concern rather than on a fixed schedule. Ask your haematologist what the follow-up schedule looks like for your specific lymphoma type and stage.

Should I pay privately for a PET between scheduled visits?

Only after discussing it with your oncologist first. Interpreting a scan result requires knowing what you are looking for, what your baseline looked like, and what a positive result would change in your management. Without that context, a private scan can produce alarming findings that require costly follow-up without changing your treatment plan. Raise the concern with your team — they may have clinical reasons to bring a scan forward.

PET-CT at CION starts from Rs 10,499 — among the lowest published prices in Hyderabad — across 4 partner centres in Banjara Hills, Punjagutta, Himayatnagar and Narayanaguda. Indicative price, as of September 2026.

Explore 62 more Family Support, Myths, Follow-Up and Emergencies topics

All Family Support, Myths, Follow-Up and Emergencies →

Your next step

Talk to an oncologist about your scan

Your PET-CT report read by a senior oncologist, explained in plain language, with a free 45-minute consultation.

Book Free Consultation Call 1800 202 8726
Common questions

Frequently asked questions

Why do guidelines say no to routine PET for most cancers?

ASCO's Choosing Wisely programme specifically identifies surveillance PET after curative treatment as a test to question for most cancers. The evidence shows it does not catch recurrence earlier than scheduled CT and tumour markers for the majority of solid tumours, while adding radiation dose, cost, and a rate of false positives that lead to unnecessary procedures. More monitoring does not always mean better monitoring.

My oncologist has not scheduled a PET for follow-up — is that correct?

For most cancer types, yes. Guideline-concordant surveillance for breast, colorectal, lung, prostate, cervical, and most other solid tumours does not include routine PET. If you are uncertain, ask your oncologist what the plan is monitoring and why it is structured the way it is. That explanation will tell you more than the presence or absence of any single scan on the schedule.

What symptoms between visits should I call my team about?

Call the same day for unexplained weight loss, fatigue that does not improve with rest, pain at or near the original site, any new lump or swelling, a persistent cough, or difficulty eating. Do not wait for your next scheduled appointment. Symptoms you notice yourself are often the earliest signal of change, and acting on them promptly is how surveillance is designed to work.

What is the difference between a post-treatment PET and ongoing surveillance PET?

A post-treatment PET is done at a specific, timed point after completing treatment to assess response — confirming remission in lymphoma, or evaluating a head and neck cancer after chemoradiotherapy. It is purposeful and defined. Ongoing surveillance PET means scheduling repeat scans over years. Guidelines broadly support the timed post-treatment use in specific cancers; open-ended repeat scheduling is what the evidence does not support for most.

Can I ask for a PET scan for peace of mind?

You can raise it with your oncologist, and should if anxiety is affecting your daily life. A negative result does not guarantee no recurrence — it shows no detectable activity at that moment. A false-positive finding can add months of distressing follow-up. The more useful step is usually the conversation about what your team is watching for and what symptoms to report between appointments.

How long does cancer surveillance continue after treatment?

It varies by cancer type and stage. Most plans are most intensive in the first years after treatment and taper in frequency over time. Ask your oncologist for a written schedule showing what is being monitored, how often, and when the plan is expected to change. Knowing the shape of the plan ahead of time gives you a clearer picture than any individual scan result.

Call now Book free consultation